Cagrilintide 10mg

A long-acting, investigational peptide therapy developed by Novo Nordisk. It mimics the natural hormone amylin to suppress appetite, increase feelings of fullness, and slow stomach emptying. It is currently being studied as a standalone weight-loss monotherapy and in a highly effective combination with GLPs